Skip navigation
Text Size
Aug.06
10:21 AM ET
Wednesday, 6 Aug 2008
Dorfman's Rx for Your Portfolio

John Dorfman's prescription for a portfolio:  A pharmaceutical, a defense contractor, a media company, and a technology stock.

He has no illusions about the bull market being back.

"I'm actually looking for a rally around October," the portfolio manager of the Dorfman Value Fund told CNBC.  "I think the next couple of months, though, continue to look kind of rough and painful to me."

Recommendations:

Topping his list is Pfizer [PFE  Loading...      ()   ].

"As long as the economy is sputtering, the drug stocks are defensive, and they have lovely dividend yields," he said.  "For instance, Pfizer is yielding between 6 and 7 (percent)...these are stocks that have been hammered down, in most cases, five years in a row, and they're selling at multiples like tobacco stocks."

He also likes ceramic armor-maker Ceradyne [CRDN  Loading...      ()   ].

Also on his list is media giant Gannett [GCI  Loading...      ()   ].

"Yes, newspapers are in a secular decline, they're losing advertising to new media, but, Gannett has a lot more to it than that," he explained. "It has 900 publications in addition to newspapers; it has something like 23 TV stations; it has a lot of internet sites; they have a lot of ways of purveying information, and I just think the stock has been hammered excessively."

Rounding out his selections is technical component maker Ladish [LDSH  Loading...      ()   ].

Disclosures:

Disclosure information for John Dorfman was not immediately available.

Disclaimer

© 2008 CNBC.com

Permalink: /id/26043179

HOME  |  NEWS  |  MARKETS  |  EARNINGS  |  INVESTING  |  VIDEO  |  CNBC TV  |  CNBC PLUS  |  CNBC MOBILE  |  CNBC HD+
About CNBC   |   Site Map   |   Privacy Policy   |   Terms of Service   |   Advertise   |   Help   |   Feedback   |   Video Reprints
  Data is a real-time snapshot   *Data is delayed at least 15 minutes

Global Business and Financial News, Stock Quotes, and Market Data and Analysis